Stock Performance

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Upcoming & Recent Events

IR PR Contacts

Investor Contact:
Argot Partners
(212) 600-1902
Email: apellis@argotpartners.com

Media Relations:
Tracy Vineis
(617) 420-4839
Email: media@apellis.com

Receive Email Alerts

Sign up to receive email alerts whenever Apellis Pharmaceuticals, Inc. posts new information to the site. Just enter your email address and click Submit.